Toregem Biopharma

toregem.co.jp /en/home_en

1/8
2/8
3/8
Toregem Bio Pharma Co., Ltd. est une start-up de l'Université de Kyoto qui a été fondée
en mai 2020 dans le but de recherche, développement et lancement d'un médicament
anticorps contre la régénération dentaire basé sur les résultats de recherche du Dr Katsu
Takahashi, chirurgie buccale et maxillo-faciale. , Université de Kyoto.

4/8
Co-fondateur Katsu Takahashi・Honoka Kiso・Muneo Takatani

Représentant

5/8
President Honoka Kiso

Toregem Bio Pharma Co., Ltd. is a startup venture from Kyoto University that was born in
May 2020.
We started a business based on the research results of Dr. Takahashi, Department of
Oral and Maxillofacial Surgery, Kyoto University.

When I was a junior high school student, I lost two teeth due to a mandibular bone
disease and had an inpatient surgery. That experience led me to become a dentist. When
I was a college student, I had an implant treatment for the lost tooth.
I wanted to study the cause of my illness and how to regenerate lost teeth, so I went on to
graduate school in 2008, and since then I have been involved in research on tooth
regeneration by Dr. Takahashi.
I am also a lucky person who was able to administer antibodies to tooth loss model mice
and first confirm that they had teeth. My peers dentists asked me, “Is it okay for your head
to grow teeth with medicine !?”, And of course I was surprised at the unbelievable results,
but it’s true. Beginning with mouse research, the effect has now been confirmed in dogs
with tooth loss.

6/8
Sometimes, I was forced to think about shrinking or withdrawing due to the exhaustion of
research expenses, and there were times when I was sluggish with no results, but by all
means I want to deliver this drug that grows teeth with a single injection to patients safely.
And with the support of various people, the team as a whole has broken through to this
point.

Toregem BioPharma first hope to treat patients with congenital tooth loss who do not
grow permanent tooth buds due to genetic causes.

With this treatment Toregem BioPharma provides solutions to children and their parents
who visit the dental hospitals seeking treatment for congenital and other dental anomalies
(like anodontia, acquired tooth defects and tooth decay).

Toregem BioPharma’s , final goal is to offer advanced & scientifically driven clinical
solution for the growth of teeth derived from their own tissues.

Healthy teeth offers healthy food intake which helps in improving quality of life. Toregem
Bio Pharma with its innovation driven drugs/therapies for tooth regeneration hopes to
improve and realise a healthy and prosperous society for the people dealing with dental
issues around the world.

Company

Read More

Access

Read More

Company

Read More

Access

Read More

Development project

7/8
Preparation

Read More

8/8